Please login to the form below

Not currently logged in
Email:
Password:

Aurobindo

This page shows the latest Aurobindo news and features for those working in and with pharma, biotech and healthcare.

Teva sells UK and Ireland assets to Intas Pharma for £603m

Teva sells UK and Ireland assets to Intas Pharma for £603m

In the weeks leading up to the sale, generic drugmaker Aurobindo and private equity firms Cinven and Apollo Global Management were reported as being in negotiations over the purchase.

Latest news

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    140. Generis. Aurobindo. Company acquisition. Generic products. 135. Maverick. Takeda. Option to acquire.

  • Pharma deals in July 2015 Pharma deals in July 2015

    In early 2014 Actavis sold most of its European generics business to Aurobindo and in March 2015 completed the acquisition of Allergan.

  • Pharma deals during January 2014 Pharma deals during January 2014

    Slimming the business down a little, Actavis sold some of its generic products in France, Italy, Spain, Portugal, Belgium, Germany and the Netherlands to Aurobindo for $41m.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Ramprasad Reddy to chair Aurobindo’s US business

    Ramprasad Reddy to chair Aurobindo’ s US business. Will also step down from position as full-time director. ... In addition, Aurobindo's board also approved that Ramprasad Reddy relinquish his executive responsibilities as full-time director of the

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics